Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

AβPP-induced UPR Transcriptomic Signature of Glial Cells to Oxidative Stress as an Adaptive Mechanism to Preserve Cell Function and Survival.

Chalour N, Maoui A, Rat P, Massicot F, Dutot M, Faussat AM, Devevre E, Limb A, Warnet JM, Treton J, Dinet V, Mascarelli F.

Curr Alzheimer Res. 2018;15(7):643-654. doi: 10.2174/1567205015666180119101832.

PMID:
29357794
2.

Thinning of the RPE and choroid associated with T lymphocyte recruitment in aged and light-challenged mice.

Camelo S, Calippe B, Lavalette S, Dominguez E, Hur J, Devevre E, Guillonneau X, Raoul W, Sennlaub F.

Mol Vis. 2015 Sep 2;21:1051-9. eCollection 2015.

3.

Profiling of the three circulating monocyte subpopulations in human obesity.

Devêvre EF, Renovato-Martins M, Clément K, Sautès-Fridman C, Cremer I, Poitou C.

J Immunol. 2015 Apr 15;194(8):3917-23. doi: 10.4049/jimmunol.1402655. Epub 2015 Mar 18.

4.

Delta-like 4 inhibits choroidal neovascularization despite opposing effects on vascular endothelium and macrophages.

Camelo S, Raoul W, Lavalette S, Calippe B, Cristofaro B, Levy O, Houssier M, Sulpice E, Jonet L, Klein C, Devevre E, Thuret G, Duarte A, Eichmann A, Leconte L, Guillonneau X, Sennlaub F.

Angiogenesis. 2012 Dec;15(4):609-22. doi: 10.1007/s10456-012-9290-0. Epub 2012 Aug 7. Erratum in: Angiogenesis. 2013 Apr;16(2):479-80.

5.

Human melanoma-specific CD8(+) T-cells from metastases are capable of antigen-specific degranulation and cytolysis directly ex vivo.

Mahnke YD, Devevre E, Baumgaertner P, Matter M, Rufer N, Romero P, Speiser DE.

Oncoimmunology. 2012 Jul 1;1(4):467-530.

6.

Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific cytotoxic T lymphocytes after vaccination with low peptide dose.

Lövgren T, Baumgaertner P, Wieckowski S, Devêvre E, Guillaume P, Luescher I, Rufer N, Speiser DE.

Cancer Immunol Immunother. 2012 Jun;61(6):817-26. doi: 10.1007/s00262-011-1140-1. Epub 2011 Nov 12.

PMID:
22080404
7.

Exhaustion of tumor-specific CD8⁺ T cells in metastases from melanoma patients.

Baitsch L, Baumgaertner P, Devêvre E, Raghav SK, Legat A, Barba L, Wieckowski S, Bouzourene H, Deplancke B, Romero P, Rufer N, Speiser DE.

J Clin Invest. 2011 Jun;121(6):2350-60. doi: 10.1172/JCI46102. Epub 2011 May 9.

8.

Differentiation associated regulation of microRNA expression in vivo in human CD8+ T cell subsets.

Salaun B, Yamamoto T, Badran B, Tsunetsugu-Yokota Y, Roux A, Baitsch L, Rouas R, Fayyad-Kazan H, Baumgaertner P, Devevre E, Ramesh A, Braun M, Speiser D, Autran B, Martiat P, Appay V, Romero P.

J Transl Med. 2011 Apr 20;9:44. doi: 10.1186/1479-5876-9-44.

9.

Memory and effector CD8 T-cell responses after nanoparticle vaccination of melanoma patients.

Speiser DE, Schwarz K, Baumgaertner P, Manolova V, Devevre E, Sterry W, Walden P, Zippelius A, Conzett KB, Senti G, Voelter V, Cerottini JP, Guggisberg D, Willers J, Geldhof C, Romero P, Kündig T, Knuth A, Dummer R, Trefzer U, Bachmann MF.

J Immunother. 2010 Oct;33(8):848-58. doi: 10.1097/CJI.0b013e3181f1d614.

PMID:
20842051
10.

Quantitative multiparameter assays to measure the effect of adjuvants on human antigen-specific CD8 T-cell responses.

Derré L, Jandus C, Baumgaertner P, Posevitz V, Devêvre E, Romero P, Speiser DE.

Methods Mol Biol. 2010;626:231-49. doi: 10.1007/978-1-60761-585-9_16.

PMID:
20099132
11.

Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time.

Iancu EM, Corthesy P, Baumgaertner P, Devevre E, Voelter V, Romero P, Speiser DE, Rufer N.

J Immunol. 2009 Jul 1;183(1):319-31. doi: 10.4049/jimmunol.0803647.

12.

Dominant human CD8 T cell clonotypes persist simultaneously as memory and effector cells in memory phase.

Touvrey C, Derré L, Devevre E, Corthesy P, Romero P, Rufer N, Speiser DE.

J Immunol. 2009 Jun 1;182(11):6718-26. doi: 10.4049/jimmunol.0803095.

13.

Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumors.

Bricard G, Cesson V, Devevre E, Bouzourene H, Barbey C, Rufer N, Im JS, Alves PM, Martinet O, Halkic N, Cerottini JC, Romero P, Porcelli SA, Macdonald HR, Speiser DE.

J Immunol. 2009 Apr 15;182(8):5140-51. doi: 10.4049/jimmunol.0711086.

14.

A Role for cis Interaction between the Inhibitory Ly49A receptor and MHC class I for natural killer cell education.

Chalifour A, Scarpellino L, Back J, Brodin P, Devèvre E, Gros F, Lévy F, Leclercq G, Höglund P, Beermann F, Held W.

Immunity. 2009 Mar 20;30(3):337-47. doi: 10.1016/j.immuni.2008.12.019.

15.

Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen.

Speiser DE, Baumgaertner P, Voelter V, Devevre E, Barbey C, Rufer N, Romero P.

Proc Natl Acad Sci U S A. 2008 Mar 11;105(10):3849-54. doi: 10.1073/pnas.0800080105. Epub 2008 Mar 4. Erratum in: Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10632.

16.

A novel population of human melanoma-specific CD8 T cells recognizes Melan-AMART-1 immunodominant nonapeptide but not the corresponding decapeptide.

Derré L, Ferber M, Touvrey C, Devevre E, Zoete V, Leimgruber A, Romero P, Michielin O, Lévy F, Speiser DE.

J Immunol. 2007 Dec 1;179(11):7635-45.

17.

Sensitive gene expression profiling of human T cell subsets reveals parallel post-thymic differentiation for CD4+ and CD8+ lineages.

Appay V, Bosio A, Lokan S, Wiencek Y, Biervert C, Küsters D, Devevre E, Speiser D, Romero P, Rufer N, Leyvraz S.

J Immunol. 2007 Dec 1;179(11):7406-14.

18.

In Vivo Persistence of Codominant Human CD8+ T Cell Clonotypes Is Not Limited by Replicative Senescence or Functional Alteration.

Derré L, Bruyninx M, Baumgaertner P, Devevre E, Corthesy P, Touvrey C, Mahnke YD, Pircher H, Voelter V, Romero P, Speiser DE, Rufer N.

J Immunol. 2007 Aug 15;179(4):2368-79.

19.

Four functionally distinct populations of human effector-memory CD8+ T lymphocytes.

Romero P, Zippelius A, Kurth I, Pittet MJ, Touvrey C, Iancu EM, Corthesy P, Devevre E, Speiser DE, Rufer N.

J Immunol. 2007 Apr 1;178(7):4112-9.

20.

IL-12 controls cytotoxicity of a novel subset of self-antigen-specific human CD28+ cytolytic T cells.

Barbey C, Baumgaertner P, Devevre E, Rubio-Godoy V, Derre L, Bricard G, Guillaume P, Luescher IF, Liénard D, Cerottini JC, Romero P, Rufer N, Speiser DE.

J Immunol. 2007 Mar 15;178(6):3566-74.

21.

Human effector CD8+ T lymphocytes express TLR3 as a functional coreceptor.

Tabiasco J, Devêvre E, Rufer N, Salaun B, Cerottini JC, Speiser D, Romero P.

J Immunol. 2006 Dec 15;177(12):8708-13.

22.

A novel approach to characterize clonality and differentiation of human melanoma-specific T cell responses: spontaneous priming and efficient boosting by vaccination.

Speiser DE, Baumgaertner P, Barbey C, Rubio-Godoy V, Moulin A, Corthesy P, Devevre E, Dietrich PY, Rimoldi D, Liénard D, Cerottini JC, Romero P, Rufer N.

J Immunol. 2006 Jul 15;177(2):1338-48.

23.

LiveCount Assay: concomitant measurement of cytolytic activity and phenotypic characterisation of CD8(+) T-cells by flow cytometry.

Devêvre E, Romero P, Mahnke YD.

J Immunol Methods. 2006 Apr 20;311(1-2):31-46. Epub 2006 Feb 24.

PMID:
16527300
24.

Dextramers: new generation of fluorescent MHC class I/peptide multimers for visualization of antigen-specific CD8+ T cells.

Batard P, Peterson DA, Devêvre E, Guillaume P, Cerottini JC, Rimoldi D, Speiser DE, Winther L, Romero P.

J Immunol Methods. 2006 Mar 20;310(1-2):136-48. Epub 2006 Feb 17.

PMID:
16516226
25.

Ex vivo detectable human CD8 T-cell responses to cancer-testis antigens.

Baumgaertner P, Rufer N, Devevre E, Derre L, Rimoldi D, Geldhof C, Voelter V, Liénard D, Romero P, Speiser DE.

Cancer Res. 2006 Feb 15;66(4):1912-6.

Supplemental Content

Loading ...
Support Center